{"id":"https://openalex.org/W2145807241","doi":"https://doi.org/10.1111/j.1751-7176.2012.00667.x","title":"The Effects of Aldosterone Synthase Inhibition on Aldosterone and Cortisol in Patients With Hypertension: A Phase II, Randomized, Double\u2010Blind, Placebo\u2010Controlled, Multicenter Study","display_name":"The Effects of Aldosterone Synthase Inhibition on Aldosterone and Cortisol in Patients With Hypertension: A Phase II, Randomized, Double\u2010Blind, Placebo\u2010Controlled, Multicenter Study","alternate_titles":[],"publication_year":2012,"publication_date":"2012-06-07","ids":{"openalex":"https://openalex.org/W2145807241","doi":"https://doi.org/10.1111/j.1751-7176.2012.00667.x","mag":"2145807241","pmid":"https://pubmed.ncbi.nlm.nih.gov/22947355","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8108872"},"language":"en","primary_location":{"id":"doi:10.1111/j.1751-7176.2012.00667.x","doi":"https://doi.org/10.1111/j.1751-7176.2012.00667.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1751-7176.2012.00667.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1751-7176.2012.00667.x","source":{"id":"https://openalex.org/S154226970","display_name":"Journal of Clinical Hypertension","issn_l":"1524-6175","issn":["1524-6175","1751-7176"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Hypertension","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2145807241"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1751-7176.2012.00667.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065699710","display_name":"Karl K Andersen","orcid":"https://orcid.org/0000-0001-5473-7794","observed_orcids":["https://orcid.org/0000-0001-5473-7794"]},"institutions":[{"id":"https://openalex.org/I165368041","display_name":"University of Iceland","ror":"https://ror.org/01db6h964","country_code":"IS","type":"education","lineage":["https://openalex.org/I165368041"]},{"id":"https://openalex.org/I4210106610","display_name":"National University Hospital of Iceland","ror":"https://ror.org/011k7k191","country_code":"IS","type":"healthcare","lineage":["https://openalex.org/I4210106610"]}],"countries":["IS"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Karl Andersen","raw_affiliation_strings":["Encode Clinic, Reykjavik, Iceland. andersen@landspitali.is","From the Encode Clinic, Reykjavik, Iceland","the Cardiovascular Research Centre, University of Iceland, Landspitali University Hospital, Reykjavik, Iceland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Encode Clinic, Reykjavik, Iceland. andersen@landspitali.is","institution_ids":["https://openalex.org/I4210106610"]},{"raw_affiliation_string":"From the Encode Clinic, Reykjavik, Iceland","institution_ids":[]},{"raw_affiliation_string":"the Cardiovascular Research Centre, University of Iceland, Landspitali University Hospital, Reykjavik, Iceland","institution_ids":["https://openalex.org/I165368041","https://openalex.org/I4210106610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022482278","display_name":"Daniel Hartman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniel Hartman","raw_affiliation_strings":["the Great Lakes Drug Development, Inc, Brighton, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Great Lakes Drug Development, Inc, Brighton, MI","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018503331","display_name":"Thomas Peppard","orcid":"https://orcid.org/0000-0003-2052-4007","observed_orcids":["https://orcid.org/0000-0003-2052-4007"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Peppard","raw_affiliation_strings":["the Great Lakes Drug Development, Inc, Brighton, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Great Lakes Drug Development, Inc, Brighton, MI","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103999908","display_name":"David J. Hermann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Hermann","raw_affiliation_strings":["the Great Lakes Drug Development, Inc, Brighton, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Great Lakes Drug Development, Inc, Brighton, MI","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029633772","display_name":"Peter J. Van Ess","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Van Ess","raw_affiliation_strings":["the Great Lakes Drug Development, Inc, Brighton, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Great Lakes Drug Development, Inc, Brighton, MI","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080343259","display_name":"Martin P. Lefkowitz","orcid":"https://orcid.org/0000-0002-8830-6316","observed_orcids":["https://orcid.org/0000-0002-8830-6316"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Lefkowitz","raw_affiliation_strings":["the Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065799721","display_name":"Angelo J. Trapani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Angelo Trapani","raw_affiliation_strings":["the Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":["https://openalex.org/I4210117619"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5065699710"],"corresponding_institution_ids":["https://openalex.org/I165368041","https://openalex.org/I4210106610"],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":4.1337,"has_fulltext":true,"cited_by_count":72,"citation_normalized_percentile":{"value":0.94198647,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"14","issue":"9","first_page":"580","last_page":"587"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aldosterone-synthase-inhibition","display_name":"aldosterone synthase inhibition","score":0.9919999837875366},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7609999775886536},{"id":"https://openalex.org/keywords/aldosterone","display_name":"aldosterone","score":0.8679999709129333},{"id":"https://openalex.org/keywords/cortisol","display_name":"cortisol","score":0.9869999885559082},{"id":"https://openalex.org/keywords/renin-angiotensin-aldosterone-system","display_name":"renin-angiotensin-aldosterone system","score":0.9330000281333923},{"id":"https://openalex.org/keywords/acth-stimulation-test","display_name":"ACTH stimulation test","score":0.6729999780654907},{"id":"https://openalex.org/keywords/adrenal-insufficiency","display_name":"adrenal insufficiency","score":0.753000020980835},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.656000018119812},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8040000200271606},{"id":"https://openalex.org/keywords/cyp11b2","display_name":"CYP11B2","score":0.8320000171661377},{"id":"https://openalex.org/keywords/cyp11b1","display_name":"CYP11B1","score":0.8690000176429749},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.3409999907016754}],"concepts":[{"id":"https://openalex.org/C2778525890","wikidata":"https://www.wikidata.org/wiki/Q184564","display_name":"Aldosterone","level":2,"score":0.92374587059021},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8308976888656616},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7034026384353638},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6810479164123535},{"id":"https://openalex.org/C2776069600","wikidata":"https://www.wikidata.org/wiki/Q422519","display_name":"Mineralocorticoid","level":3,"score":0.5499038100242615},{"id":"https://openalex.org/C2780249997","wikidata":"https://www.wikidata.org/wiki/Q14904983","display_name":"Aldosterone synthase","level":4,"score":0.5145248770713806},{"id":"https://openalex.org/C189135053","wikidata":"https://www.wikidata.org/wiki/Q3454531","display_name":"Mineralocorticoid receptor","level":3,"score":0.43640458583831787},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.41522276401519775},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.3515205979347229}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000450","descriptor_name":"Aldosterone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006854","descriptor_name":"Hydrocortisone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019405","descriptor_name":"Cytochrome P-450 CYP11B2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062186","descriptor_name":"Arterial Pressure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1751-7176.2012.00667.x","doi":"https://doi.org/10.1111/j.1751-7176.2012.00667.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1751-7176.2012.00667.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1751-7176.2012.00667.x","source":{"id":"https://openalex.org/S154226970","display_name":"Journal of Clinical Hypertension","issn_l":"1524-6175","issn":["1524-6175","1751-7176"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Hypertension","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8108872","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8108872/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Hypertens (Greenwich)","raw_type":"Text"},{"id":"pmid:22947355","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22947355","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical hypertension (Greenwich, Conn.)","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:www.hirsla.lsh.is:2336/295042","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2336/295042","pdf_url":null,"source":{"id":"https://openalex.org/S4306401083","display_name":"Hirsla (Landsp\u00edtali University Hospital)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210106610","host_organization_name":"National University Hospital of Iceland","host_organization_lineage":["https://openalex.org/I4210106610"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1111/j.1751-7176.2012.00667.x","doi":"https://doi.org/10.1111/j.1751-7176.2012.00667.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1751-7176.2012.00667.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1751-7176.2012.00667.x","source":{"id":"https://openalex.org/S154226970","display_name":"Journal of Clinical Hypertension","issn_l":"1524-6175","issn":["1524-6175","1751-7176"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Hypertension","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2145807241.pdf","grobid_xml":"https://content.openalex.org/works/W2145807241.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W2010799694","https://openalex.org/W2105095326","https://openalex.org/W2109712401","https://openalex.org/W2115013092","https://openalex.org/W2125560773","https://openalex.org/W2143954917","https://openalex.org/W2148589377","https://openalex.org/W2152094259","https://openalex.org/W2164705414","https://openalex.org/W2177640000","https://openalex.org/W2303651371","https://openalex.org/W2323458614","https://openalex.org/W2328926651","https://openalex.org/W2411868239","https://openalex.org/W2607031541","https://openalex.org/W2999510508","https://openalex.org/W4206632929","https://openalex.org/W4285719527","https://openalex.org/W4376546421"],"related_works":["https://openalex.org/W1521917359","https://openalex.org/W2014029753","https://openalex.org/W2015591431","https://openalex.org/W2155377419","https://openalex.org/W2148589377","https://openalex.org/W4412551127","https://openalex.org/W2184908512","https://openalex.org/W7211902275","https://openalex.org/W7220904300","https://openalex.org/W7140475861"],"abstract_inverted_index":{"Blockade":[0],"of":[1,22,48,88,101,144,171],"the":[2,19,23,32,38,46,69,75,86,99,102,107,123,133,156],"renin-angiotensin-aldosterone":[3],"system":[4],"(RAAS)":[5],"is":[6,63],"an":[7],"established":[8],"method":[9],"to":[10,56,67,72,110,121,160,176],"lower":[11],"blood":[12],"pressure":[13],"in":[14,31,115,119,128],"patients":[15,116,135,182],"with":[16,117,166,192],"hypertension.":[17],"Aldosterone,":[18],"end":[20],"product":[21],"RAAS":[24],"cascade,":[25],"acts":[26],"by":[27],"increasing":[28,49],"salt":[29],"reabsorption":[30],"kidney":[33],"and":[34,52,82,141,149],"catecholamine":[35],"release":[36],"from":[37],"adrenal":[39,186],"medulla.":[40],"Currently":[41],"available":[42],"aldosterone":[43,51,57,79,89,148],"inhibitors":[44],"have":[45],"disadvantage":[47],"circulating":[50],"thus":[53],"may":[54,91],"lead":[55],"breakthrough.":[58],"Aldosterone":[59],"synthase":[60],"inhibition":[61],"(ASI)":[62],"a":[64,139,167],"novel":[65,103],"approach":[66],"suppressing":[68],"RAAS.":[70],"Due":[71],"homology":[73],"between":[74],"enzymes":[76],"responsible":[77],"for":[78,185],"synthesis":[80,84,90],"(CYP11B2)":[81],"cortisol":[83,94,108],"(CYP11B1),":[85],"blockade":[87],"also":[92],"suppress":[93],"release.":[95],"The":[96],"authors":[97],"evaluated":[98],"effect":[100,143],"ASI":[104],"LCI699":[105,145,188],"on":[106,146,153],"response":[109],"adrenocorticotropic":[111],"hormone":[112],"(ACTH)":[113],"stimulation":[114],"hypertension":[118],"order":[120],"find":[122],"maximally":[124],"tolerated":[125,191],"dose":[126],"(MTD)":[127],"this":[129],"patient":[130],"population.":[131],"Among":[132],"63":[134],"evaluated,":[136],"there":[137],"was":[138,158,189],"dose-":[140],"time-dependent":[142],"both":[147],"ACTH-stimulated":[150],"cortisol.":[151],"Based":[152],"exposure-response":[154],"analysis,":[155],"MTD":[157],"estimated":[159],"be":[161],"1.30":[162],"mg":[163,173,178],"once":[164,174,179],"daily":[165,175],"90%":[168],"prediction":[169],"interval":[170],"0.88":[172],"1.81":[177],"daily.":[180],"No":[181],"required":[183],"intervention":[184],"insufficiency.":[187],"well":[190],"no":[193],"serious":[194],"adverse":[195],"events.":[196]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2145807241","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
